Disability, Inclusion and Science
Distinguished disability rights campaigner, David Ruebain, joined us last month at the Wellcome Genome Campus. He spoke on disability and inclusion in science, as part of the campus Equality in Science event series.
Science in a conflict zone: Investigating cholera in Yemen
In addition to the civil war, Yemen is experiencing the worst epidemic of cholera ever recorded. We spoke to Ankur Rakesh, a volunteer doctor with Médecins Sans Frontières (MSF) / Doctors Without Borders, who travelled to Yemen in July 2017 to study the genomics of this highly infectious and deadly disease
Hasta la VISA, genomes!
From ragworts that are too common and the tricky toughness of truffles to the trials of getting DNA samples a US Visa, Dan Mead gives his personal reflections on project managing the 25 Genomes Project
Chernobyl: chasing a ‘catching’ cancer
Sanger researcher Alex Cagan travelled to Chernobyl’s nuclear exclusion zone for samples of cancer. But he isn’t investigating the effects of the reactor disaster; his quarry has a more ancient source: the immortal cells of an 8,000 year-old animal that are still being passed from dog to dog
Human Embryo Editing: science fiction or science fact?
Anna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu's unverified announcement of gene editing the first human embryos that have been born
Dr Cordelia Langford wins BioBeat award
The ‘50 Movers and Shakers in BioBusiness 2018’ report identifies outstanding women who are developing revolutionary bioscience. Dr Cordelia Langford, Director of Scientific Operations at the Wellcome Sanger Institute is celebrated in the collaboration category. Ahead of the BioBeat 2018 conference, we spoke to Cordelia about her career and her role as a leading woman in science
